Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120 is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0.395. It has been cited 7 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0836
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
National Institute of Allergy and Infectious Disease
Grant: HHSN272201300033C
National Institute of Allergy and Infectious Disease
Grant: HHSN272201600012C
National Institutes of Health
Grant: UM1 AI068614
National Institutes of Health
Grant: UM1 AI068635
National Institutes of Health
Grant: UM1 AI068618
US Public Health Service
Grant: UM1 AI069453
Bill and Melinda Gates Foundation
Grant: OPP1017604
University of Rochester
Grant: UM1
University of Rochester
Grant: AI069511
NIAID NIH HHS
Grant: U01 AI069511
NIAID NIH HHS
Grant: UM1 AI069511
FWCI
0.86
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals